Showing results (1931-1940 of 8,157) with videos related to
Sort By:
Pageof 816
Haematologica|April 9, 2026
Understanding drug resistance in chronic myeloid leukemia through the lens of leukemic stem cell states: insights from single-cell analysesVaidehi Krishnan, Pavithra Shyamsunder, Tiong S OngHaematologica|April 9, 2026
Disease course of FLT3 mutated extramedullary acute myeloid leukemia and efficacy of gilteritinibFrancesco Angotzi, Erika Borlenghi, Chiara Sartor, et al.Haematologica|April 2, 2026
First-year results of the International Leukemia/Lymphoma Target Board for pediatric relapsed and refractory hematological malignanciesUri Ilan, Judith M Boer, Maaike Luesink, et al.Haematologica|April 9, 2026
FLT3 inhibition after transplantation: real-world evidence confirms common practiceMartin BornhäuserHaematologica|April 9, 2026
Impact of horse anti-thymocyte globulin on graft-versus-host disease after human leukocyte antigen-matched related bone marrow transplantation for severe aplastic anemiaDaniel J Olivieri, Ted Gooley, Shivaprasad Manjappa, et al.Haematologica|April 16, 2026
An unusual case of basophilic meningitis revealing a chronicphase chronic myeloid leukemia: a report after almost three years of follow-upRamy Rahmé, Matteo Dragani, Carole Fleury, et al.Haematologica|April 16, 2026
Gene expression profile of adult T-cell leukemia/lymphoma with human T-cell lymphotropic virus type 1-infected Hodgkin and Reed-Sternberg-like cells is more similar to classic Hodgkin lymphoma than typical adult T-cell leukemia/lymphomaShohei Miyagi, Kyohei Mori, Kohta Miyawaki, et al.Haematologica|April 23, 2026
Circulating tumor DNA at baseline as a prognostic marker in untreated follicular lymphomaCorinna Lutterbeck, Derrick Kaufman, Christopher R Bolen, et al.Haematologica|May 7, 2026
Breaking barriers in rare disease research: a pilot trial of thromboprophylaxis with apixaban versus aspirin in JAK2-Positive myeloproliferative neoplasmsMiriam Kimpton, Sonia Cerquozzi, Dominique Toupin, et al.Haematologica|May 7, 2026
Myelodysplastic syndrome with concomitant SF3B1 mutation and deletion of chromosome 5 long arm: outcomes and response to treatmentRami Komrokji, Zaker Schwabkey, Zena Komrokji, et al.Pageof 816